Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic?

被引：127
作者：
Freemantle, N [1 ]
机构：
[1] Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England
来源：
BRITISH MEDICAL JOURNAL | 2001年 / 322卷 / 7292期
关键词：
D O I：
10.1136/bmj.322.7292.989
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：989 / 991
页数：3
相关论文
共 16 条
[1]   Subgroup analysis and other (mis)uses of baseline data in clinical trials [J].
Assmann, SF ;
Pocock, SJ ;
Enos, LE ;
Kasten, LE .
LANCET, 2000, 355 (9209) :1064-1069
[2]   The evidence for β blockers in heart failure -: Equals or surpasses that for angiotensin converting enzyme inhibitors [J].
Cleland, JGF ;
McGowan, J ;
Clark, A ;
Freemantle, N .
BRITISH MEDICAL JOURNAL, 1999, 318 (7187) :824-825
[3]  
*DEP HHS FDA, 1998, FED REGISTER, V63, P49583
[4]   Carvedilol and the food and drug administration (FDA) approval process: The FDA paradigm and reflections on hypothesis testing [J].
Fisher, LD .
CONTROLLED CLINICAL TRIALS, 1999, 20 (01) :16-39
[5]   SOMETHING ROTTEN IN THE STATE OF CLINICAL AND ECONOMIC EVALUATIONS [J].
FREEMANTLE, N ;
MAYNARD, A .
HEALTH ECONOMICS, 1994, 3 (02) :63-67
[6]   Problems with the interpretation of pharmacoeconomic analyses - A review of submissions to the Australian pharmaceutical benefits scheme [J].
Hill, SR ;
Mitchell, AS ;
Henry, DA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (16) :2116-2121
[7]   Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure -: The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF) [J].
Hjalmarson, Å ;
Goldstein, S ;
Fagerberg, B ;
Wedel, H ;
Waagstein, F ;
Kjekshus, J ;
Wikstrand, J ;
El Allaf, D ;
Vítovec, J ;
Aldershvile, J ;
Halinen, M ;
Dietz, R ;
Neuhaus, KL ;
Jánosi, A ;
Thorgeirsson, G ;
Dunselman, PHJM ;
Gullestad, L ;
Kuch, J ;
Herlitz, J ;
Rickenbacher, P ;
Ball, S ;
Gottlieb, S ;
Deedwania, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (10) :1295-1302
[8]   End-point interpretation in clinical trials:: The case for discipline [J].
Moyé, LA .
CONTROLLED CLINICAL TRIALS, 1999, 20 (01) :40-49
[9]  
*NAT I CLIN EXC, 2001, INT GUID MAN SPONS
[10]   A CONSUMERS GUIDE TO SUBGROUP ANALYSES [J].
OXMAN, AD ;
GUYATT, GH .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (01) :78-84
12